These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 21237556)
1. AN N-terminal Smac peptide sensitizes human prostate carcinoma cells to methyl jasmonate-induced apoptosis. Jiang G; Zhao J; Xiao X; Tao D; Gu C; Tong Q; Luo B; Wang L; Zeng F Cancer Lett; 2011 Mar; 302(1):37-46. PubMed ID: 21237556 [TBL] [Abstract][Full Text] [Related]
2. Predominant enhancement of apoptosis induced by methyl jasmonate in bladder cancer cells: therapeutic effect of the Antp-conjugated Smac peptide. Xiao XY; Jiang GS; Wang L; Lv L; Zeng FQ Anticancer Drugs; 2011 Oct; 22(9):853-63. PubMed ID: 21642838 [TBL] [Abstract][Full Text] [Related]
3. Delayed cytotoxic effects of methyl jasmonate and cis-jasmone induced apoptosis in prostate cancer cells. Yeruva L; Pierre KJ; Bathina M; Elegbede A; Carper SW Cancer Invest; 2008 Nov; 26(9):890-9. PubMed ID: 18798057 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of expression of anti-apoptotic protein Bcl-2 and induction of cell death in radioresistant human prostate adenocarcinoma cell line (PC-3) by methyl jasmonate. Ezekwudo D; Shashidharamurthy R; Devineni D; Bozeman E; Palaniappan R; Selvaraj P Cancer Lett; 2008 Nov; 270(2):277-85. PubMed ID: 18573594 [TBL] [Abstract][Full Text] [Related]
5. Smac peptide potentiates TRAIL- or paclitaxel-mediated ovarian cancer cell death in vitro and in vivo. Mao HL; Pang Y; Zhang X; Yang F; Zheng J; Wang Y; Liu P Oncol Rep; 2013 Feb; 29(2):515-22. PubMed ID: 23151974 [TBL] [Abstract][Full Text] [Related]
7. Methyl jasmonate induced apoptosis in human prostate carcinoma cells via 5-lipoxygenase dependent pathway. Ezekwudo DE; Wang RC; Elegbede JA J Exp Ther Oncol; 2007; 6(4):267-77. PubMed ID: 18038760 [TBL] [Abstract][Full Text] [Related]
8. J7, a methyl jasmonate derivative, enhances TRAIL-mediated apoptosis through up-regulation of reactive oxygen species generation in human hepatoma HepG2 cells. Park C; Jin CY; Hwang HJ; Kim GY; Jung JH; Kim WJ; Yoo YH; Choi YH Toxicol In Vitro; 2012 Feb; 26(1):86-93. PubMed ID: 22079975 [TBL] [Abstract][Full Text] [Related]
9. Methyl jasmonate downregulates expression of proliferating cell nuclear antigen and induces apoptosis in human neuroblastoma cell lines. Tong QS; Jiang GS; Zheng LD; Tang ST; Cai JB; Liu Y; Zeng FQ; Dong JH Anticancer Drugs; 2008 Jul; 19(6):573-81. PubMed ID: 18525316 [TBL] [Abstract][Full Text] [Related]
10. [Methyl jasmonate induces apoptosis of human neuroblastoma cell line BE(2) -C and its mechanism]. Jiang GS; Tong QS; Zeng FQ; Hu B; Zheng LD; Cai JB; Liu Y Yao Xue Xue Bao; 2008 Jun; 43(6):584-90. PubMed ID: 18822959 [TBL] [Abstract][Full Text] [Related]
11. Methyl jasmonate reduces the survival of cervical cancer cells and downregulates HPV E6 and E7, and survivin. Milrot E; Jackman A; Kniazhanski T; Gonen P; Flescher E; Sherman L Cancer Lett; 2012 Jun; 319(1):31-8. PubMed ID: 22198483 [TBL] [Abstract][Full Text] [Related]
12. Methyl jasmonate sensitizes human bladder cancer cells to gambogic acid-induced apoptosis through down-regulation of EZH2 expression by miR-101. Wang Y; Xiang W; Wang M; Huang T; Xiao X; Wang L; Tao D; Dong L; Zeng F; Jiang G Br J Pharmacol; 2014 Feb; 171(3):618-35. PubMed ID: 24490857 [TBL] [Abstract][Full Text] [Related]
13. Methyl jasmonate: a plant stress hormone as an anti-cancer drug. Cohen S; Flescher E Phytochemistry; 2009 Sep; 70(13-14):1600-9. PubMed ID: 19660769 [TBL] [Abstract][Full Text] [Related]
14. Methyl jasmonate induces cell cycle block and cell death in the amitochondriate parasite Trichomonas vaginalis. Ofer K; Gold D; Flescher E Int J Parasitol; 2008 Jul; 38(8-9):959-68. PubMed ID: 18294640 [TBL] [Abstract][Full Text] [Related]
15. Methyl jasmonate decreases membrane fluidity and induces apoptosis through tumor necrosis factor receptor 1 in breast cancer cells. Yeruva L; Elegbede JA; Carper SW Anticancer Drugs; 2008 Sep; 19(8):766-76. PubMed ID: 18690087 [TBL] [Abstract][Full Text] [Related]
16. Concomitant activation of caspase-9 and down-regulation of IAP proteins as a mechanism of apoptotic death in HepG2, T47D and HCT-116 cells upon exposure to a derivative from 4-aryl-4H-chromenes family. Mahdavi M; Davoodi J; Zali MR; Foroumadi A Biomed Pharmacother; 2011 Jun; 65(3):175-82. PubMed ID: 21565459 [TBL] [Abstract][Full Text] [Related]
17. Methyl jasmonate induces cell death with mixed characteristics of apoptosis and necrosis in cervical cancer cells. Kniazhanski T; Jackman A; Heyfets A; Gonen P; Flescher E; Sherman L Cancer Lett; 2008 Nov; 271(1):34-46. PubMed ID: 18599197 [TBL] [Abstract][Full Text] [Related]
18. Chemosensitization of Prostate Carcinoma Cells with a Receptor-directed Smac Conjugate. Sturzu A; Sheikh S; Echner H; Deeg M; Nägele T; Weidenmaier C; Schwentner C; Horger M; Ernemann U; Heckl S Med Chem; 2016; 12(5):412-8. PubMed ID: 26558373 [TBL] [Abstract][Full Text] [Related]
19. Natural jasmonates of different structures suppress the growth of human neuroblastoma cell line SH-SY5Y and its mechanisms. Tong QS; Jiang GS; Zheng LD; Tang ST; Cai JB; Liu Y; Zeng FQ; Dong JH Acta Pharmacol Sin; 2008 Jul; 29(7):861-9. PubMed ID: 18565287 [TBL] [Abstract][Full Text] [Related]
20. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide. Yang L; Mashima T; Sato S; Mochizuki M; Sakamoto H; Yamori T; Oh-Hara T; Tsuruo T Cancer Res; 2003 Feb; 63(4):831-7. PubMed ID: 12591734 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]